|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 02703990.8 (espacenet) (Federated) (European Patent Register), 20020228 | Patent/reg. no. and date | DK/EP 1374895, 20100630 | Publication date | 20040102 | Priority no. and date | US 798076, 20010228 | EP pub. no. and date |
EP 1374895 20040102 | Effective date | | Applicant/owner | Instituto Bioclon S.A. de CV., Calzada de Tlalpan No. 4687 Col. Toriello Guerra Delegación Tlalpan
14050 México, D.F., MX | Applicant ref. no. | 62983 | Inventor | Juan Lopez de Silanes, Lucerna No. 7, Col. Juarez
Delegacion Cuauthtémoc, MX, Rita Mancilla Nava, Calzada de Tlalpan No. 4687, Colonia Toriello Guerra
Delegacion Tlalpan 14050, MX, Jorge F. Paniagua Solis, Amores No. 1304, Colonia del Valle
Delegacion Benito Juarez 03100, MX | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/18 (2006.01) | Title | Farmaceutisk sammensætning af F(AB) 2-fragmenter af antistoffer og fremgangsmåde til fremstilling heraf | Int. application no. | MX2002000013 | Int. publication no. | WO2002068475 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |